The Future of Drug Discovery: Who Decides Which Diseases to Treat?

The Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer’s disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease.

Provides an in-depth, broad perspective on the crisis in drug industryExposes the disconnect between what society needs and what the drug companies are working onAnalyses and projects over 10 years into the futureExplains what it means for scientists and societyDetermines what is needed to be done to make sure that the industry responds to society's needs, remains commercially attractive and answers the question as to who decides which diseases to treat

00 – Introduction for the non-specialist

01 – Why there will be new drugs despite the ongoing ‘crisis’ of drug development in big pharma

02 – The need for medicine grows

03 – Medicines are becoming better

04 – Which diseases do we want to treat?

05 – Therapeutic Areas: strategically important diseases for the future

06 – Blockbuster proprietary drugs versus generic drugs

07 – Why is pharma a special industry?

08 – Diagnosing towards personalized medicine

09 – Personalized medicine

10 – How much can drugs cost?

11 – Modeling Drug Discovery until 2025

12 – Drug development models between 2010 and 2025